Search
for

    Sort by

    Research 811–840 of 1000+

    1. Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates General and Comparative Endocrinology · 2020 · 21 citations
    2. Dermatologic Conditions in Transgender Populations Endocrinology and Metabolism Clinics of North America · 2019 · 21 citations
    3. Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study Archives of Gynecology and Obstetrics · 2015 · 21 citations
    4. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis Clinical Endocrinology · 2017 · 20 citations
    5. Novel inhibitors of 5α-reductase Expert Opinion on Therapeutic Patents · 2002 · 20 citations
    6. A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome Fertility and Sterility · 2000 · 20 citations
    7. HAIR MATRIX CELL KINETICS: A SELECTIVE REVIEW International Journal of Dermatology · 1978 · 20 citations
    8. Insulin sensitivity, androgens and isotretinoin therapy in women with severe acne Journal of Dermatological Treatment · 2012 · 19 citations
    9. Hypothalamic DNA methylation in rats with dihydrotestosterone‐induced polycystic ovary syndrome: effects of low‐frequency electro‐acupuncture Experimental physiology · 2018 · 18 citations
    10. 5α-Reductase Inhibitors, Chemical and Clinical Models Steroids · 1998 · 17 citations
    11. Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography British Journal of Dermatology · 2012 · 16 citations
    12. Co-secretion of testosterone and cortisol by a functional adrenocortical oncocytoma Histopathology · 2007 · 16 citations
    13. Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients Revista Brasileira de Ginecologia e Obstetrícia · 2018 · 15 citations
    14. Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome Scientific Reports · 2023 · 14 citations
    15. Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study Journal of Bone and Mineral Metabolism · 2017 · 14 citations
    16. Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute women Steroids · 2007 · 14 citations
    17. Female Androgenic Alopecia Archives of Dermatology · 1986 · 14 citations
    18. Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment Scientific Reports · 2024 · 13 citations
    19. Morpho‐regulation in diverse chicken feather formation: Integrating branching modules and sex hormone‐dependent morpho‐regulatory modules Development, Growth & Differentiation · 2018 · 13 citations
    20. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia The Journal of Sexual Medicine · 2019 · 11 citations
    21. Age-Related Differences for Male-to-Female Transgender Patients Undergoing Gender-Affirming Surgery Sexual Medicine · 2019 · 11 citations
    22. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome Gynecological Endocrinology · 2015 · 10 citations
    23. Nanomilled Oral Testosterone Plus Dutasteride Effectively Normalizes Serum Testosterone in Normal Men With Induced Hypogonadism International Journal of Andrology · 2008 · 10 citations
    24. Polymorphism of CAG and GGN repeats of androgen receptor gene in women with polycystic ovary syndrome Reproductive Biomedicine Online · 2015 · 9 citations
    25. CYP21A2 Mutations in Women with Polycystic Ovary Syndrome (PCOS) Hormone and Metabolic Research · 2013 · 9 citations
    26. Polycystic ovary syndrome Journal Of Endocrinology, Metabolism And Diabetes Of South Africa · 2009 · 9 citations
    27. Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome Reproductive Biology and Endocrinology · 2021 · 8 citations
    28. Serum irisin: A prognostic marker for severe acne vulgaris Journal of Cosmetic Dermatology · 2018 · 8 citations
    29. The role of antimullerian hormone in the hormonal workup of women with persistent acne Journal of Cosmetic Dermatology · 2016 · 8 citations
    30. Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping Clinical Chemistry · 2016 · 8 citations